Galapagos

Galapagos is a Belgium-based biotechnology company that discovers, develops and commercializes small molecule medicines to the treatment of inflammatory and fibrotic diseases.

Business Model:

Revenue: $517.2M

Employees: 1,001-5,000

Detailed Galapagos Information

Geographic Data

Galapagos headquarters map

Address: Generaal De Wittelaan L11 A3

City: Mechelen

State: other

Zip: 2800

Country: BE

Financial Info

Stage:

post ipo equity

Raised Last:

$5B

Raised Total:

$283M

Metrics

37,832Website Global Rank

3,000,601Website Monthly Traffic

Twitter Followers

Description

Galapagos is a Belgium-based biotechnology company that discovers, develops and commercializes small molecule medicines to the treatment of inflammatory and fibrotic diseases.

Contact Phone:
+13215342900

Contact Email:

Galapagos went public on 10/5/2017 on the Other

Listed Exchange:
Other

IPO Date:
10/5/2017

Ticker Symbol:
GLPG

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
7/2013 Vitalnext Funding Round -
7/2013 Vitalnext Funding Round -

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2018 Post-IPO Equity $300M
11/2002 Grant $0 The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders
1/2013 Grant $3.6M
10/2010 Grant $5.1M
1/2014 Grant $4M
8/2007 Venture Round 1 - Thuja Capital
Thuja Capital
Thuja Capital
Thuja Capital
7/2019 Post-IPO Equity 1 $5.1B Gilead Sciences
Gilead Sciences
Gilead Sciences
Gilead Sciences
1/2014 Post-IPO Equity 1 - Van Herk Ventures
Van Herk Ventures
Van Herk Ventures
Van Herk Ventures
10/2007 Grant $7.4M
1/2015 Grant 1 $2.8M University of Antwerp
University of Antwerp
1/2013 Grant $3.5M
2/2009 Grant $1M
10/2007 Grant -
1/2015 Grant $2.9M
5/2015 IPO $275.4M
3/2009 Grant $0 The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders
6/2002 Grant $0 The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders
1/2001 Venture Round 1 - Gilde Healthcare
Gilde Healthcare
3/2002 Venture Round $18.6M
10/2007 Grant -
1/2014 Post-IPO Equity 1 - Van Herk Ventures
Van Herk Ventures
Van Herk Ventures
Van Herk Ventures
3/2009 Grant 1 $1.1M The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders
8/2007 Venture Round 1 - Thuja Capital
Thuja Capital
Thuja Capital
Thuja Capital
Announced Date Name Price
6/2022 CellPoint
6/2021 Abound Bio
1/2013 Cangenix
2/2010 Argenta Discovery
1/2007 ProStrakan
12/2006 Inpharmatica
9/2005 BioFocus DPI

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research